Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive

He brings more than 30 years of leadership and operations experience in healthcare to the firm

Canadian firm Valeant Pharmaceuticals International has appointed Joseph C. Papa as Chairman and Chief Executive.

Papa joins Valeant from Perrigo, a developer, manufacturer and distributor of over-the-counter (OTC) and prescription (Rx) pharmaceuticals, where he was Chairman and Chief Executive. He will also join Valeant's Board of Directors and succeed J. Michael Pearson.

Papa has been CEO of Perrigo since 2006 and was appointed as Chairman of the Board of Directors of Perrigo in 2007. Prior to Perrigo, he was Chairman and Chief Executive of the Pharmaceutical and Technologies Services segment of Cardinal Health.

Earlier in his career, he was President and Chief Operating Officer of Watson Pharmaceuticals. Prior to this, Novartis and Pharmacia/Searle, he was responsible for overseeing the launches of Diovan, Celebrex and Lotrel.

You may also like